A qPCR to quantify Wolbachia from few Onchocerca volvulus microfilariae as a surrogate for adult worm histology in clinical trials of antiwolbachial drugs.


Journal

Parasitology research
ISSN: 1432-1955
Titre abrégé: Parasitol Res
Pays: Germany
ID NLM: 8703571

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 30 08 2021
accepted: 14 12 2021
pubmed: 11 1 2022
medline: 9 4 2022
entrez: 10 1 2022
Statut: ppublish

Résumé

The filarial nematode Onchocerca volvulus causes onchocerciasis (river blindness), a neglected tropical disease affecting 21 million people, mostly in Sub-Saharan Africa. Targeting the endosymbiont Wolbachia with antibiotics leads to permanent sterilization and killing of adult worms. The gold standard to assess Wolbachia depletion is the histological examination of adult worms in nodules beginning at 6 months post-treatment. However, nodules can only be used once, limiting the time points to monitor Wolbachia depletion. A diagnostic to longitudinally monitor Wolbachia depletion from microfilariae (MF) at more frequent intervals < 6 months post-treatment would accelerate clinical trials of antiwolbachials. We developed a TaqMan qPCR amplifying the single-copy gene wOvftsZ to quantify Wolbachia from as few as one MF that had migrated from skin biopsies and compared quantification using circular and linearized plasmids or synthetic dsDNA (gBlock®). qPCR for MF from the rodent nematode Litomosoides sigmodontis was used to support the reproducibility and validate the principle. The qPCR using as few as 2 MF from O. volvulus and L. sigmodontis reproducibly quantified Wolbachia. Use of a linearized plasmid standard or synthesized dsDNA resulted in numbers of Wolbachia/MF congruent with biologically plausible estimates in O. volvulus and L. sigmodontis MF. The qPCR assay yielded a median of 48.8 (range 1.5-280.5) Wolbachia/O. volvulus MF. The qPCR is a sensitive tool for quantifying Wolbachia in a few MF from skin biopsies and allows for establishing the qPCR as a surrogate parameter for monitoring Wolbachia depletion in adult worms of new antiwolbachial candidates.

Identifiants

pubmed: 35006317
doi: 10.1007/s00436-021-07411-5
pii: 10.1007/s00436-021-07411-5
pmc: PMC8986682
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1199-1206

Subventions

Organisme : Bill and Melinda Gates Foundation
ID : OPPGH5342
Organisme : Deutsches Zentrum für Infektionsforschung, Clinical Leave Stipend
ID : TI 07.001_Schlabe_00
Organisme : Deutsches Zentrum für Infektionsforschung, Clinical Leave Stipend
ID : TI 07.001_Schlabe_01
Organisme : Deutsches Zentrum für Infektionsforschung
ID : TI 03.907
Organisme : Deutsche Forschungsgemeinschaft
ID : EXC2151 - 390873048

Informations de copyright

© 2022. The Author(s).

Références

Lancet. 2001 May 5;357(9266):1415-6
pubmed: 11356444
PLoS Negl Trop Dis. 2018 Jan 4;12(1):e0006116
pubmed: 29300732
PLoS Negl Trop Dis. 2017 Jan 5;11(1):e0005156
pubmed: 28056021
Clin Infect Dis. 2020 Aug 14;71(4):933-943
pubmed: 31536624
Clin Infect Dis. 2006 Apr 15;42(8):1081-9
pubmed: 16575724
Parasit Vectors. 2012 Jan 13;5:16
pubmed: 22243803
Parasitol Res. 2009 Dec;106(1):23-31
pubmed: 19756742
Med Microbiol Immunol. 2008 Sep;197(3):295-311
pubmed: 17999080
PLoS One. 2011;6(12):e29101
pubmed: 22194997
Filaria J. 2003 May 9;2(1):10
pubmed: 12801420
Sci Transl Med. 2019 Mar 13;11(483):
pubmed: 30867321
Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1414-1419
pubmed: 30617067
PLoS Pathog. 2012 Sep;8(9):e1002922
pubmed: 23028321
PLoS Negl Trop Dis. 2019 Mar 20;13(3):e0007218
pubmed: 30893296
PLoS Negl Trop Dis. 2013 Apr 25;7(4):e2169
pubmed: 23634234
PLoS Negl Trop Dis. 2019 Feb 28;13(2):e0007159
pubmed: 30818326
J Parasitol. 1977 Dec;63(6):1007-18
pubmed: 592029
PLoS Negl Trop Dis. 2019 Aug 5;13(8):e0007636
pubmed: 31381563
PLoS Pathog. 2021 Jul 22;17(7):e1009682
pubmed: 34293063
PLoS Negl Trop Dis. 2020 Jul 6;14(7):e0008427
pubmed: 32628671
Clin Infect Dis. 2015 Aug 15;61(4):517-26
pubmed: 25948064
PLoS One. 2010 Mar 05;5(3):e9545
pubmed: 20221433
Biotechniques. 2018 Apr;64(4):177-179
pubmed: 29661012

Auteurs

Stefan Schlabe (S)

Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Patricia Korir (P)

German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Christine Lämmer (C)

German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Frederic Landmann (F)

Centre de Recherche de Biologie Cellulaire de Montpellier (CRBM), Université de Montpellier, CNRS, 34293, Montpellier, France.

Bettina Dubben (B)

German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Marianne Koschel (M)

German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Anna Albers (A)

German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Linda Batsa Debrah (LB)

Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana.
Department of Clinical Microbiology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Alexander Yaw Debrah (AY)

Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana.
Faculty of Allied Health Sciences of Kwame, Nkrumah University of Science and Technology, Kumasi, Ghana.

Marc P Hübner (MP)

German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Kenneth Pfarr (K)

German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany. Kenneth.Pfarr@ukbonn.de.
Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany. Kenneth.Pfarr@ukbonn.de.

Ute Klarmann-Schulz (U)

German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Achim Hoerauf (A)

German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH